A citation-based method for searching scientific literature

John B Buse, Richard M Bergenstal, Leonard C Glass, Cory R Heilmann, Michelle S Lewis, Anita Y M Kwan, Byron J Hoogwerf, Julio Rosenstock. Ann Intern Med 2011
Times Cited: 389







List of shared articles



Times cited




Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same?
Raffaella Gentilella, Valeria Pechtner, Antonella Corcos, Agostino Consoli. Diabetes Metab Res Rev 2019
80

Incretin-based therapy in type 2 diabetes: An evidence based systematic review and meta-analysis.
Greer Waldrop, Jixin Zhong, Matthew Peters, Aditya Goud, Yin-Hsiu Chen, Stephen N Davis, Bhramar Mukherjee, Sanjay Rajagopalan. J Diabetes Complications 2018
15


Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?
Inka Miñambres, Antonio Pérez. Diabetol Metab Syndr 2017
12



The Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Type 2 Diabetes.
Erin St Onge, Shannon Miller, Elizabeth Clements, Lindsay Celauro, Ke'la Barnes. J Transl Int Med 2017
3

Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes.
Kelvin Lingjet Tran, Young In Park, Shalin Pandya, Navin John Muliyil, Brandon David Jensen, Kovin Huynh, Quang T Nguyen. Am Health Drug Benefits 2017
47

Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trials.
Matteo Monami, Ilaria Dicembrini, Besmir Nreu, Francesco Andreozzi, Giorgio Sesti, Edoardo Mannucci. Acta Diabetol 2017
17


Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: a review.
L Østergaard, Christian S Frandsen, S Madsbad. Expert Rev Clin Pharmacol 2016
17